Alex Cohen, CEO of Hello Patient, discusses his personal biohacking routine and experience undergoing Testosterone Replacement Therapy (TRT) with host Molly O'Shea.
Assertion Not checkable as stated
Cohen: Anthropic's Claude is too slow for real-time phone calls
“We've tried Gemini, Claude and Anthropic are a little bit too slow for a phone call, unfortunately.”
Prediction Not checkable as stated
Cohen: Hello Patient has a 2-3 year head start over EHR incumbents
“I think we still have a two to three year head start to like really get good and ingrain and go sell and be like best in class at patient engagement because they're really that last 10% really does matter.”
Insight
Cohen: Taking GLP-1s for weight loss is no different than taking creatine
“I don't think people should be judged for taking it either. I think there's a lot of like stigma around it and people are like, you cheated at losing weight. And it's like, I don't see how it's different than taking creatine to put on, you know, water weight a…”
Assertion Supported
Cohen: Hello Patient raised a $22.5M Series A
“We've raised a 22 and a half million dollar Series A.”
Prediction Open · timeframe Sep 2030
Cohen: Incumbent EHR giants will not be unseated in 3-5 years
“Like, the EHRs aren't going anywhere. Epic has a complete, basically, like, oligopoly over the entire space. ModMen and Athena are massive companies. Like, I don't think anyone is unseating them in the next three to five years”
Prediction Open · timeframe Sep 2028
Cohen: Jony Ive and Sam Altman will announce AI glasses
“I think it's gonna be a pair of glasses. I think, like, that's the only form function that my, again, like, Johnny genuinely, like, understands the future, I think, of, god, I'm, like, going into acting mode, but, like, he genuinely understands the like, hardw…”